At the critical moment of the pharmaceutical industry's green and low-carbon transformation, Shanghai Tsuenjikang Pharmaceutical Technology Co., Ltd.'s Hebei production demonstration base once again realized a technological breakthrough, extending the shelf life of the plant capsule products from 36 months to 48 months.On May 14th, this innovation successfully completed the CDE filing, which marks that the plant capsule technology has reached a new level, and at the same time, it has provided a new impetus to reduce the waste of medicines, to promote the safety of medicines, to enhance the quality standard of pharmaceutical industry and to promote sustainable development. It also injects new impetus to reduce drug waste, promote national drug safety, enhance the quality standard of pharmaceutical industry and promote sustainable development.
01Practicing social responsibility, promoting national drug safety
Tsuenjikang has always integrated social responsibility into its corporate development strategy. From 24 months to 36 months, and now 48 months, every breakthrough in plant capsule technology has demonstrated the ultimate pursuit of drug quality and safety.
This technical achievement is also a positive response to the national policy. on December 29, 2023, the National Health Commission and other five departments issued the Implementation Plan for Saving Pharmaceutical Resources and Curbing the Waste of Medicines, which explicitly proposes to reduce the waste of medicines from the source and improve the level of rational use of medicines. This shelf-life extension technology sets a model for the industry to conserve drug resources.
Drug expiration date management is an important part of drug quality control. This technological breakthrough is not only in line with the GMP and GSP specifications formulated by WHO, but also provides strong support for the implementation of China's Drug Administration Law, which further guarantees the safety of drugs in circulation.
02 Technical innovation: the shelf life of plant capsules exceeds 48 months
The extension of the shelf life of drugs is not only a technological advancement, but also has far-reaching significance in drug resource management, drug safety and environmental protection. Compared with the shelf life of traditional gelatin capsules, which is generally 18-24 months, Tsuenjikang plant capsule products have achieved a breakthrough of 48 months, demonstrating its excellent stability and environmental advantages.
Reduce drug waste
The extended shelf life of medicines effectively reduces the scrapping rate of expired medicines, making the inventory management of medical institutions and pharmacies more efficient, and patients, especially those with chronic diseases, are able to avoid the trouble of wasted expired medicines.
Optimizing Supply Chain Resilience
During emergencies such as epidemics, a long-lasting and stable supply of medicines is crucial. A longer shelf life helps to mitigate market fluctuations and safeguard public health.
Reduce operational costs
Longer shelf life reduces the frequency of drug storage and transportation, lowering associated costs while creating more economic and social value for drug manufacturers and healthcare systems.
03Green Development: The Future Potential of Vegetable Encapsulation Technology
Led by the “dual-carbon” strategy, green technology has become an important driving force for the transformation and upgrading of the pharmaceutical industry. Plant capsules are gradually replacing traditional gelatin capsules due to their environmental characteristics and stability, helping the industry to realize high-quality development.
The extension of shelf life not only saves production and operation costs for enterprises, but also enhances market competitiveness and social responsibility. At the same time, this technological breakthrough provides more innovative space for drug research and development, which is expected to give rise to more green and high-end pharmaceutical preparations, injecting new momentum for the future development of the pharmaceutical industry.
In the future, we will use technological innovation to drive green development, make every effort to ensure national drug safety, contribute to the “China Solution”, and help build a human health community.
With innovation as our engine, we will continue to empower the green development of the pharmaceutical industry!
